Objective: The addition of exogenous high molecular weight hyaluronic acid (HA) reverses cartilage damage caused by fibronectin fragments (Fn-fs) added to explant cultures of bovine and human cartilage and by Fn-fs in an experimental in vivo model of rabbit knee joint damage.
Introduction
Hyaluronic acid or hyaluronan (HA), has been tested as a therapeutic intervention in the treatment of osteoarthritis (OA) 1 . Intra-articular HA treatment of the knee of patients with OA has been shown to reduce painful symptoms and improve joint mobility [2] [3] [4] [5] [6] . One report suggested that repeated intra-articular injections of HA weakly affect the structural progression of OA in clinical patients 7 ; however, that conclusion will need to be strengthened with further studies. In contrast to the reports of efficacy [2] [3] [4] [5] [6] , a recent placebo-controlled trial failed to show positive results 8 . Further, the results of a study that showed that HA reduced one parameter of pain when compared with saline controls 9 or with low molecular weight HA forms 10 , have been challenged 11 . The complexities of interpretation of these clinical trials and discussion of limitations of some of these studies have been reviewed 12 .
Investigations of the effects of HA in animal models have been less controversial. It has been shown in a Pond-Nuki canine model, which involves severance and resection of the anterior cruciate ligament, that HA causes significant reduction of cartilaginous lesions and delays progression of cartilage degradation 13 . In another anterior cruciate ligament animal model in rabbits, HA decreased damage to femoral condyles as measured by gross inspection, cartilage thickness, presence of collagen cross-links and hexosamine content 14 . In a bilateral canine osteoarthritis rabbit model, HA was effective up to 6 months after injection and prevented progression of OA 15 . HA also reduced histopathology in a partial menisectomy model of OA in rabbit knee 16 . In another partial meniscectomy rabbit model, HA enhanced meniscal regeneration and inhibited cartilage degeneration as long as 6 months post-surgery, suggesting a long-term effect. In this study, there was a trend toward increased proteoglycan (PG) content and less morphological degradation in HA-treated medial tibial articular cartilage 17 . In one study of a rabbit anterior cruciate ligament transection model, the effect of HA on matrix metalloproteinases (MMPs) and cytokines was investigated. It was found that HA reduced the grade of cartilage damage, but did not block MMP production in cartilage, although it did so in synovium 18 .
There have been many studies on the effects of HA in simpler systems, for example in cartilage explant or chondrocyte culture models. HA has also been shown to block PG release caused by addition of catabolic cytokines to cultured cartilage [19] [20] [21] ; however, the mechanism is unknown. One possible mechanism may be that HA acts as an antioxidant and blocks reactive oxygen species involved in cytokine pathways. In fact, HA was shown to inhibit IL-1-induced superoxide anion in bovine chondrocytes 22 . HA was also shown to increase PG synthesis in bovine articular cartilage in the presence of IL-1 23 .
In our investigation of the mechanisms by which HA suppresses cartilage damage, we have utilized a model of cartilage damage involving the ability of fibronectin fragments (Fn-f) to damage cartilage explants 24, 25 , through elevation of catabolic cytokines 26, 27 . This, in turn, elevates levels of MMPs [27] [28] [29] and also induces aggrecanase-like cleavage 30 . This model has been reviewed 31 . A particular useful feature of this model is that, while many of the reported studies of HA utilize cytokine models, this model is upstream of cytokine pathways and allows us to examine the effects of HA in a more physiologic pathway of a more complex nature.
In application of this model, our studies showed that HA decreased the loss of cartilage PG in Fn-f-damaged cartilage in vitro, in both bovine 32 and human cartilage 33 . Further, in a counterpart Fn-f in vivo model in which injection of Fn-f into rabbit knee joints causes marked PG loss 34, 35 , HA was also effective 36 . However, HA was also found to restore PG lost from bovine 32 and human cartilage 33 explants previously damaged by Fn-f. These reports were the first to show that HA had reparative activities in vitro. Since the damaging agents were removed to test for repair, there are likely mechanisms other than blocking penetration of the mediator that would be required to explain repair. This HA-mediated restoration of PG was associated in human cartilage with enhanced PG synthesis 33 . Whether or not the enhanced PG synthesis is due to suppression of cytokine activities through anti-oxidant activities or enhancement of anabolic pathways through other mechanisms, is not yet clear.
In order to address the question as to whether HA acts to block cytokine activities or affects other novel pathways, we have investigated as to whether the effects of repair observed in Fn-f-damaged cartilage apply to IL-1 damaged cartilage as well. We have also investigated whether this restoration of PG is persistent and, thus, of a useful nature, and whether it occurs in older bovine cartilage.
Materials and methods
All common chemicals and reagents were from Sigma Chemical Co. (St. Louis, MO). HA (800 kDa) and 5-aminofluoresceinated HA (800 kDa) were provided by Seikagaku Corporation (Tokyo, Japan). Recombinant human IL-1β (cat. number: 201-LB) was from R & D Systems, Inc. (Minneapolis, MN). Recombinant human IGF-1 was from UBI (Lake Placid, NY).
ISOLATION OF FN-F
Fn-fs were generated from human Fn as described 24 .
The Fn-f tested was a well-characterized amino-terminal 29-kDa Fn-f that has been found to be the most potent 24 and is referred to as the Fn-f.
CARTILAGE EXPLANT CULTURES
Cartilages from 18-month-old as well as cartilage from older 6-year-old bovines were studied (Research 87, Marlboro, MA). Only macroscopic-appearing normal cartilage was used in all the cases. Culturing of slices of bovine metacarpophalangeal cartilage was performed as described 30 in Dulbecco's modified Eagle's medium (DMEM) containing 50 U/ml penicillin-streptomycin in 10% fetal bovine serum/DMEM or in DMEM alone, and with 50-80 mg cartilage per 2 ml/well. The medium was changed every other day. Each datum was based on assays of three culture wells treated identically.
PG-CONTENT OF CARTILAGE AND ASSAYS OF PG DEPLETION
The total amount of PG/mg wet weight cartilage was determined by assays with dimethylmethylene blue (DMB) reagent after treatment of 50-80 mg of cartilage in 1.0 ml of 50 mM phosphate buffer, pH 6, containing 10 mM EDTA and 10 mM cysteine, with 50 µg/ml papain for 16 h at 65°C as originally described [25] [26] [27] . To assay PG, a volume of 0.8 ml DMB reagent, prepared as described 24 , was mixed with 190 µl of 1.37 M GuHCl and 10 µl of test sample. After 2 min, a spectrophotometer was used to determine absorbances at 525 and 595 nm, using water as a blank. The ratios of 525 nm absorbance over 595 nm absorbance were used to establish a standard curve with purified PG and a standard curve of 0.5-3 µg/ml purified bovine PG was used to estimate PG contents in the papain digests. The data are reported as µg PG/mg wet weight cartilage based on a mean and standard deviation (SD) of at least three cartilage samples. The data were compared by unpaired t test analysis. A P value <0.05 was considered significant.
TESTS OF EFFECTS OF HA ON BLOCKING FN-F OR IL-1β-MEDIATED DAMAGE, ON RESTORING PG AND ON STABILITY OF REPAIR
To test for blocking activity, to 10% serum/DMEM cultures, HA was typically added to a final concentration of 1 mg/ml. After 4 h, the Fn-f was added to a final 0.1 µM concentration or IL-1β was added to a final 10 ng/ml concentration. Every 7 days during the 28 to 42-day culture period, cartilage was removed, the dry weight was determined and the cartilage was subjected to assays of PG content.
To test for restoration of PG, cartilage was cultured with 0.1 µM Fn-f or 10 ng/ml IL-1β for 7 or 14 days in 10% serum/DMEM in order to remove about half of the total cartilage matrix PG. At 7 or 14 days, HA was added to a final 1 mg/ml concentration. Every 7 days, for up to 42 days, cartilage was removed for assays of total PG content.
To test for stability of repair, cartilage was cultured with Fn-fs or IL-1β for 7 days as described before to deplete about half of the cartilage PG and then cultured with 1 mg/ml HA in 10% serum/DMEM for an additional period. The HA was then removed at various times, and culturing continued in 10% serum/DMEM alone. Slices were removed for PG content analysis each of the 7 days. Fl-HA (provided by Seikagaku Corp, Tokyo, Japan) was added at a final concentration of 1 mg/ml to cultured 18-month-old bovine cartilage in 10% serum/DMEM for 7 days. Cartilage was recovered, washed exhaustively with DMEM and subjected to cryosectioning (10 µm). The sections were then mounted in glycerol on slides and visualized with an Olympus BH-2 microscope equipped with epifluorescence using appropriate filters for fluorescein. A ×10 objective and ×2 ocular were used to photograph with 400 ASA Kodak Tri-X film pushed to 1600 ASA with 4 min per exposure.
Results

RESTORATION OF PG BY HA DID NOT REVERSE AFTER REMOVAL OF HA FROM FN-F-DAMAGED CARTILAGE
We had shown earlier that 1 mg/ml HA blocked the ability of the Fn-f to deplete PG content in cultures in 10% serum/DMEM and that HA also partially restored PG to normal or above levels by day 21 in cartilage first treated with Fn-f 32, 33 . In order to investigate the stability of HAmediated restoration of PG, cartilage was first treated with Fn-fs for 7 days in 10% serum/DMEM to deplete PG, and was then treated with 1 mg/ml HA for periods of 7, 14, 21 or 35 days during a 42-day culture period. As shown in Fig. 1 (A), 7 days of HA treatment (F [d0-7]; HA [d7-14] curve) was sufficient for a full restoration of PG, and the restoration was stable up to day 42 or up to 4 weeks after the HA was removed. At days 14, 21, 28, 35 and 42, the PG content for the F (d0-7); HA (d7-14) curve were significantly different than Fn-f treatment at P values of 0.045, 0.01, 0.003, 0.002 and 0.001, respectively. The curves for HA (d7-21) and HA (d7-42) were very similar to the HA (d7-14) curve with similar levels of significant difference when each was compared with Fn-f treatment. PG content in the repair curves appeared to be greater than control levels, but did not reach significant difference.
In another set of experiments, the response of cartilage exposed to Fn-f for twice as long, for 14 days, was investigated. Figure 1 (B) shows that restoration of PG to control levels occurred after an exposure to HA for as short a period as 7 days (F [d0-14]; HA [d14-28] curve) (Pϭ 0.18 for 7 days when experimental compared with control). A decreased effect is suggested by the decrease in PG content at day 35 for the days 14-28 HA treatment (Pϭ 0.14 for experimental vs control and P<0.005 for experimental vs Fn-f). This decreased effect was also observed at day 42.
When cartilage was damaged with Fn-f in the presence of 0.1% serum present throughout the experiment, a greater degree of PG depletion occurred, but HA, added at day 7, did not promote restoration of PG (data not shown). Therefore, either the greater degree of damage or the lower concentration of serum components decreased the potential for repair.
In other experiments, when cartilage was first damaged by Fn-f and HA was substituted with 1 mg/ml methylcellulose, with viscosity similar to that of HA, restoration of PG did not occur (data not shown). Further, methylcellulose did not block Fn-f-mediated damage.
HA REMAINED ASSOCIATED WITH CARTILAGE MATRIX DURING CULTURE PERIOD
In order to determine as to how long cartilage treated with HA retained the HA and where HA bound, Fl-HA was added to the 10% serum/DMEM media of cultured cartilage between day 0 and 7, and the excess Fl-HA was removed at day 7. Sections were analyzed for fluorescence at various time points. Figure 2 shows that in controls not treated with HA (−HA) there was no detectable fluorescence. Ph shows a typical phase contrast of the control tissue. C7, C14 and C28 show cartilage after treatment with Fl-HA between day 0 and 7, and are then analyzed at days 7, 14 and 28. Similar cultures were also treated with Fn-f between day 0 and 7 as well as Fl-HA, and the media Fl-HA was removed as with the control cultures. F7, F14 and F28 show the respective Fn-f-treated sections. Note that fluorescence is still detected up to 21 days after removal of HA In order to determine whether the blocking and reparative effects of HA were unique to Fn-f-mediated damage, another catabolic mediator, IL-1β, was used as a test Figure 3 (A) shows that preincubation of cartilage with 1 mg/ml HA, followed by addition of IL-1β, resulted in a major loss of PG by day 7 (Pϭ0.0002 for experimental vs control), a loss similar to that of IL-1β alone (Pϭ0.02 for experimental vs control). However, HA did facilitate restoration of PG in cartilage first exposed to IL-1β for 7 days as shown inFig. 3(B). Restoration occurred to levels that were significantly greater than IL-1β-treated levels (Pϭ0.038, 0.0009, 0.001, 0.001 for IL-1 vs IL-1/HA treatment at days 14, 21, 28 and 35, respectively). The restored levels at days 28 and 35 were also significantly greater than the control untreated levels (P<0.03 and 0.02, respectively).
RESTORATION OF PG BY HA DID NOT OCCUR AFTER REMOVAL OF HA FROM IL-1β-DAMAGED CARTILAGE IF THE DAMAGE PERIOD WAS PROLONGED
The stability of restoration of PG in IL-1β-damaged cartilage was investigated ( Fig. 4) . Panel A shows that restoration of PG occurred after only a 14-day treatment with HA (IL [d0-7]; HA [d7-14]) was significantly greater than IL-1β treatment alone (P<0.04 at day 21). This degree of restoration was stable through day 42 (Pϭ0.003 for IL-1β vs IL-1β;HA at day 42). Restoration of PG was more complete after HA treatment for 28 days (IL [d0-7]; HA [d7-28] curve) and was at control levels at day 28 (Pϭ 0.8 when experimental compared with untreated control) and above control levels at days 35 and 42 (Pϭ0.028, 0.0124, respectively). Similar results were observed with half the concentration of IL-1β, 7.5 ng/ml (data not shown). As with the earlier data, HA-treated cartilage, whether first damaged or not, showed PG contents later in culture that were greater than non-HA treated controls (Pϭ0.03, 0.015, respectively, for days 35 and 42) .
The effect of a longer damage period which would also delay introduction of HA by an additional period was also tested. As shown in Fig. 4(B) , a longer treatment for 14 days with IL-1β prevented HA from causing a stable restoration of PG. Addition of HA for 14 days, followed by its removal, did not allow a regain of PG up through day 21. At day 28, there was an increase in PG content with HAtreated cartilage to a level indistinguishable from control Fig. 1(B) , except repair was tested after treatment with 10 ng/ml IL-1β in 10% serum/DMEM from day 0 to 7. To test whether HA blocked IL-1β-mediated PG depletion, cartilage was obtained from 6-year-old bovines and cultured separately. Only normal looking cartilage, as ascertained by gross macroscopic analysis, was used. The cartilage did not have apparent fibrillation. Separate culturing was performed because of the greater potential for variability of older cartilage. As shown in Fig. 5 , the control cartilages to which nothing was added, except for specimen D, showed a significant decrease in PG content by day 7 when treated with IL-1β. The P values for day 7 data for specimens A-D, respectively, when control data were compared with IL-1 (d0-7)-treated samples were 0.0045, 0.0001, 0.0002 and 0.096. HA was not effective in blocking IL-1β-mediated PG depletion in any of the specimens, as also shown earlier for the 18-month-old cartilage. The P values for day 28 data for specimens A-D, respectively, when IL-1 (d0-7) and IL-1β, HA (d0-28) data were compared were 0.127, 0.20, 1.0 and >1.0, respectively.
However, when IL-1β was added for 7 days to deplete PG and then removed and HA was added, there was significant restoration of PG in the four different cartilage specimens within 7 days of HA treatment. The P values for day 14 data for specimens A-D, respectively, when IL-1 (d0-7) data were compared with IL-1 (d0-7); HA (d7-28) treatment were 0.045, 0.0068, 0.03 and 0.042, respectively. By day 21, restoration was almost to control levels of PG. The P values for day 21 when control and HA-treated data were compared were <0.17 for specimens A, B and C and 0.08 for specimen D. By day 28, PG restoration was more complete.
Two additional 6-year-old bovine sources showed similar results (data not shown). In other experiments, treatment with IL-1β for 14 days before HA treatment did not allow significant restoration of PG (data not shown), as also demonstrated for the cartilage explants from 18-month-old bovines. To test for repair, cartilage was cultured with 10 ng/ml IL-1β from day 0 to 7, to remove PG and then incubated with 1 mg/ml HA in 10% serum/DMEM from day 7 to 28 (IL [d0-7]; HA [d7-28]). Controls for continuous IL-1β for days 0-28 are not shown, but were similar to day 0-7 treatment. PG content was measured every 7 days.
Since we have shown that IGF-1 has reparative activity toward Fn-f-damaged cartilage 37 , we attempted to compare the reparative effects of HA with that of IGF-1 in IL-1-mediated damage. Separate cultures of 6-year-old cartilage from two different bovines (A and B) were first damaged with IL-1β for 7 days and then adjusted to 100 ng/ml IGF-1, as well as a combination of 1 mg/ml HA and IGF-1. Figure 6 shows that by day 24 with specimen A, HA, IGF-1 and a combination restored PG to control levels (P>0.2 for experimental vs control). The combination was not significantly better than HA or IGF-1 alone (P<0.2 for combination vs HA or IGF-1). At day 32, the PG content in control cartilage had decreased compared with day 24. At day 32, each treatment enhanced PG content to levels greater than control (P<0.02 for treatment vs control). Similar trends were observed for specimen B.
Discussion
We have reported that high molecular weight HA can suppress decreases in cartilage matrix PG content from both bovine metacarpophalangeal cartilage 32 and human knee cartilage 33 in the presence of Fn-fs, which we have shown to cause chondrocytic chondrolysis. We have also found that HA can promote restoration of PG in Fn-fdamaged bovine or human cartilage 32, 33 .
Our objectives were to determine whether blocking or restoration of PG were unique to Fn-f-mediated damage or would also occur in an IL-1β damage system. We have reported that Fn-fs upregulate cytokines, such as IL-1β 26, 27 and, thus, one might expect that HA-mediated repair of Fn-f-damaged cartilage should also be observed in an IL-1β damage model. However, Fn-fs upregulate TNF-α and IL-1β in a short-term pulse-like pattern, which leads to a relatively short pulse of MMP activity 26 . Other catabolic cytokines such as IL-1α and IL-6 are also upregulated 26 . However, the enhanced MMP release does not occur continuously. In contrast, in a typical IL-1β damage model, IL-1β is added continuously, but little is known as to whether MMP upregulation remains elevated during the culture period. Thus, because IL-1β is often used for a cartilage explant damage model, it was important for us to determine whether HA would also be effective in an IL-1β model.
We first confirmed that HA was effective in suppressing PG depletion in Fn-f-cultured 18-month-old bovine cartilage for up to 28 days and also in enhancing repair as we reported 32 . Additionally, we also tested the stability of this repair, which has not yet been reported. We also investigated another parameter, the role of serum and found that the restoration of PG did not occur if the serum was lowered from 10 to 0.1%. Thus, serum appears to be important in providing greater vitality for repair. This blocking activity or ability of HA to facilitate restoration of PG in 10% serum cultures was not due to a viscosity effect, as shown by our experiments with methylcellulose. The activity was not due to interaction between HA and Fn-f, since we reported earlier that HA and the Fn-f do not interact as shown by gel filtration chromatography 32 . The reparative activity also appeared to be stable in that the removal of HA after only a 7-day exposure to the damaged cartilage still allowed a full restoration of PG in Fn-f-damaged cartilage. It should also be noted that the concentration of HA we have used throughout these studies was 1 mg/ml. Since the synovial fluid concentration of HA is 2-4 mg/ml, as reviewed 12 , we are not studying effects due to the use of abnormally high concentrations of HA.
In order to provide an explanation for the stability of the repair, we tested whether a brief 7-day exposure was sufficient for binding of fluorescent HA and whether the HA remained bound once the excess HA in the culture media was removed. Fluorescence microscopy showed that the HA that bound within a 7-day exposure period remained bound to cartilage for up to 21 days, whether the cartilage was exposed to Fn-f or not. Since a concentration of 1 mg/ml of fluorescent HA was used and the synovial fluid concentration of HA is 2-4 mg/ml 12 , this binding was physiologic and not driven by an artificially high concentration of HA. Further, the fluorescence appeared to penetrate throughout the full thickness section of the cartilage and the HA appeared to surround the cells. We had reported earlier that most of the HA remained on the superficial cartilage surface; however, more sensitive detection does show that a very small fraction does become internalized. We have no explanation for how HA of 800 000 can penetrate and diffuse throughout the section. It is very possible that the very small fraction of HA that does penetrate is degraded and that this is the active fraction of HA. This will be difficult Fig. 5 were used to test for repair. Cartilage was first treated with 10 ng/ml IL-1β for 7 days in 10% serum/DMEM and was then treated with 1 mg/ml HA (HA) or 100 ng/ml IGF-1 (IGF-1) or a combination of the two (Both) from day 7 to 32. A duplicate control curve for day 0 to 7 IL-1β treatment is included.
to demonstrate because of the relative difficulty in separating this small amount of HA from the surface-bound HA and determining its mass. However, future experiments will include work in that direction. This observation of retention of HA within the cartilage matrix for weeks after the initial treatment is also consistent with our earlier report that a 1-day treatment with 1 mg/ml HA decreased the effect of the Fn-f for up to 28 days 32 . These collective results suggest that the effects of HA persist after the excess is removed from the media and that the reparative activity is not due to the solution phase HA in the media, but rather to the bound HA. Thus, the efficacy of HA in clinical studies should not be strictly dependent on the synovial fluid concentration.
Interestingly, HA did not block IL-1β-mediated damage as it did in Fn-f-mediated damage. This may be because the 29-kDa Fn-f used in this study can bind matrix components such as PG, while the IL-1β would not be expected to have specific binding affinity for matrix components. We have shown that treatment of cartilage with HA decreases penetration of Fn-f into cartilage tissue and that this cannot be due to interaction between HA and Fn-f since complexes were not observed by gel filtration chromatography 32 . We did not test whether or not HA blocked penetration of IL-1β since others have shown that HA does not alter effects of IL-1 on cartilage matrix synthesis, and this may suggest that HA does not block penetration of IL-1 20, 21 .
Most importantly, this work does show that HA can be effective in a cytokine model in terms of restoration of PG and, thus, this work supports the notion of a general effect of HA on cartilage repair. Since HA did not block IL-1mediated damage, but promoted repair, this may suggest that the potential physical effect of HA on decreasing penetration of Fn-f, as we have reported 32, 33 , probably plays only a small role in the overall chondroprotective effect of HA. While it can be argued that HA does block penetration of Fn-f and decreases damage, the most important activity of HA may be more general, and may be due to the enhancement of reparative processes.
Nonetheless, since HA helped restore PG in both Fn-f and IL-1β-damaged cartilage, it is likely that the reparative mechanism does not involve unique synergistic interaction with elements of a Fn-f damage or repair pathway, unless these elements would be similar in an IL-1β system. It is more likely that HA has direct effects on catabolic and/or anabolic pathways. It was interesting to note that a short 7-day exposure to HA was sufficient to initiate these effects in either the Fn-f or IL-1 models. Thus, HA triggers anabolic pathways or suppresses catabolic pathways that continue after removal of the bulk of the HA, consistent with our visualization of Fl-HA in cartilage weeks after removal of HA from the media.
When cartilage was cultured with IL-1β for 14 days, the restoration of PG was not stable and certainly not as stable as with prolonged Fn-f treatment. While we cannot interpret whether this relative failure to restore PG stably is due to prolonged deleterious effects of IL-1β treatment or due to the delay of introduction of HA, it does point out that there may be differences in our Fn-f model vs cytokine models. In our Fn-f models, a cytokine pulse is caused, which may be milder than the effects of continuous incubation with cytokines. Since restoration of PG was more complete with Fn-f-damaged cartilage, also with a delayed introduction of HA, it is likely that the lesser restoration of PG with prolonged IL-1β treatment is not due to the timing of introduction of HA, but rather due to the severity of the treatment. It should be noted that we have shown that continuous treatment with Fn-f does not decrease PG content [38] [39] [40] , and that the chondrocytes respond to Fn-f treatment initially with reduced PG and general protein synthesis, but later show elevated rates of synthesis, which by 28 days in culture, return to control values [38] [39] [40] . Therefore, it is unlikely that the Fn-f have caused reduced cell vitality during the more prolonged treatment. However, we did not test the effect of prolonged treatment with IL-1β on cell vitality.
Another interesting observation was that HA appeared to enhance PG content to above normal levels. Such an effect is not without precedent. We have observed this effect with other agents as well, including antioxidants 37, 41, 42 or synthetic peptides that mimic the cell-binding domain of Fn 43 or the growth factor, OP-1 44 . Further, addition of lower concentrations of Fn-f to cartilage explants, which cause enhanced PG synthesis, also enhances PG content to above normal levels [38] [39] [40] .
The observation that HA was effective on IL-1β-treated 6-year-old cartilage explants, though perhaps to a lesser degree, was encouraging since older cartilage is thought to be less capable of repair. In fact, it has been shown that bovine cartilages of this age are much less responsive to growth factors such as IGF-1 45 . Nonetheless, IGF-1 as well as HA, potently enhanced restoration of PG.
In summary, HA has been shown to be effective not only in a Fn-f model, but also in a cytokine model of cartilage damage. It has also been found to be effective long after the excess solution form of HA is removed from the cultures, and is also effective on older cartilage. Collectively, these data add to a growing literature on the efficacy of HA in in vitro models of cartilage damage. However, caution should be exercised in extrapolating our results to expectations of efficacy in clinical trials since the joint presents a much more complex milieu than our culture conditions.
